OSA is estimated to affect 10% to 30% of adults worldwide. It’s characterized by repeated upper-airway collapse during sleep, ...

A million things could make you feel tired 24/7, but this underdiagnosed condition could be to blame.

A causal link is plausible, researchers say ...

Medically reviewed by Jane Kim, MD Key Takeaways Untreated OSA can impair focus, memory, and reaction time, making work tasks ...

A disorder that causes breathing pauses during sleep, OSA affects an estimated 1% to 4% of otherwise healthy children and is linked to impaired growth, behavioral and cognitive challenges, and both ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost an ...

Tirzepatide achieved a mean apnea-hypopnea index reduction of up to 63% (about 30 fewer events per hour), meeting all primary and key secondary endpoints in two phase 3 clinical trials Tirzepatide ...

AIOMEGA® announced the first prescribed clinical use of AIO BREATHE® mandibular repositioning device, FDA-cleared for ...

By Hugo Francisco de Souza New clinical trial evidence suggests targeting both obesity and sleep-disordered breathing ...

If you are unfortunate enough to suffer from obstructive sleep apnea (OSA), there are a couple of effective ways to manage the condition. One way is to use a CPAP machine. The alternative is to use a ...